RET and cancer: Numerous studies have shown that the PI3K/AKT/mTOR pathway is an essential signaling pathway that is activated by the oncogenic RET, which subsequently promotes the survival of cancer cells through the phosphorylation of mammalian target of rapamycin (mTOR) protein [7].